Advertisement
Journal Home
Search for

Volume 155, Issue 3, Pages 374-379 (September 2009)


View previous. 30 of 76 View next.

School-Centered Telemedicine for Children with Type 1 Diabetes Mellitus

Roberto Izquierdo, MDa, Philip C. Morin, MS, CCRPa, Kathleen Bratt, PNP, CDEa, Zoryana Moreau, FNP, CDEa, Suzanne Meyer, RN, CDEa, Robert Ploutz-Snyder, PhDa, Michael Wade, MSa, Ruth S. Weinstock, MD, PhDab

Received 4 October 2008; received in revised form 5 January 2009; accepted 9 March 2009. published online 22 May 2009.

Objectives

To test the feasibility and effectiveness of telemedicine to improve care of children with type 1 diabetes in schools.

Study design

Subjects, ages 5 to 14 years (grades kindergarten through eighth) were randomized to usual care (18 students; 13 schools) or intervention (23 students; 12 schools). Usual care included medical visits every 3 months and communication between school nurse and diabetes team as needed by phone. The intervention group received usual care plus a telemedicine unit in the school nurse office to videoconference between the school nurse, child, and diabetes team every month. Hemoglobin A1c and pediatric quality of life were measured every 3 months for 1 year. Analyses used multilevel modeling.

Results

A1c values increased from baseline to 6 months for students in the usual care group and decreased in the telemedicine cohort (P < .02). Lower A1c levels in the telemedicine group were maintained over the next several months, and significant improvements in several subscales of the Pediatric Diabetes Quality of Life questionnaire were observed. In the telemedicine group, urgent diabetes-related calls initiated by the school nurse were significantly reduced, and there were fewer hospitalizations and emergency department visits.

Conclusions

A school telemedicine program can improve diabetes care in grades kindergarten through eighth.

a Departments of Pediatrics and Medicine, SUNY Upstate Medical University and Medical Service, Syracuse, NY

b Department of Veterans Affairs Medical Center, Syracuse, NY

 Supported by Department of Health and Human Services (equipment), New York State Department of Health; and the Children's Miracle Network. LifeScan Inc., donated home glucose monitoring devices and test strips for this project. The authors declare no conflicts of interest.

 ClinicalTrials.gov identifier: NCT00566475.

 No Reprints offered.

PII: S0022-3476(09)00234-0

doi:10.1016/j.jpeds.2009.03.014


View previous. 30 of 76 View next.

Advertisement